drugset / Trial / NCT01192581
Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection as Adjunctive Therapy in Subjects With Internal Carotid Artery Hypoperfusion
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to evaluate the effectiveness, safety and tolerability of consistent dosages of the study drug (hydroxyethyl starch 130/0.4 and sodium chloride injection, Vuloven) administrated intravenously for 7 days.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-04
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vuloven | Unknown | 500 mg | Intravenous |
| Subject | Vuloven | Unknown | 1000 mg | Intravenous |
| Subject | Vuloven | Unknown | 1500 mg | Intravenous |